Community Medicine — Immunisation Programmes and Stewardship, NMC MBBS licence examination syllabus (Nepal Medical Council).
Two topics, one idea: some medical decisions affect people who are not your patient.
Almost everything else in medicine is a transaction between you and the person in front of you. You weigh the benefit to them against the risk to them, and they decide.
Vaccination and antibiotic prescribing break that model. A vaccinated child protects the newborn in the next house. An unnecessary antibiotic course selects resistant organisms that will infect somebody else entirely, months from now. In both cases the consequences land on people who never entered your consulting room — which is why both are public health subjects and not only clinical ones.
An infection needs a chain of susceptible people to keep going. When enough of a population is immune, that chain breaks — the organism runs out of new hosts before it can sustain transmission.
The people this protects are precisely those who cannot be protected directly:
Where herd immunity does not apply: tetanus. Clostridium tetani lives in soil and is not transmitted person to person, so no amount of community coverage protects an unvaccinated individual. Each person must be immunised on their own account. That contrast is a favourite examination question because it tests whether you understand the mechanism rather than the slogan.
A vaccine is a biological product, and most lose potency if they are not held within a specific temperature range from manufacture all the way to the arm. The chain runs through national stores, district stores, health posts and outreach sessions, and it is only as strong as its weakest link.
Two failure modes matter, and the second surprises people:
Too warm is the obvious one — potency degrades. Too cold is just as real: several vaccines are damaged by freezing, and freezing happens accidentally when a refrigerator is set too low or a vaccine sits against the cooling element or on an ice pack.
The danger in both directions is the same, and it is what makes cold chain failure so serious: a vaccine that has lost potency looks completely normal. It is administered, the child is recorded as immunised, the family believes the child is protected, and nobody discovers otherwise until an outbreak tears through a population that was supposed to be covered.Storage temperatures are deliberately not quoted here — they differ between vaccines, they are safety-critical, and a remembered range applied to the wrong product spoils a batch. Use the product information and your national guideline.
A national coverage figure is an average, and an average hides its distribution. A country can report an impressive national number while containing districts, communities and urban slums where coverage is very low.
Why does that matter? Because susceptible children are not scattered randomly. They cluster — by geography, by poverty, by migration, by ethnicity, by belief. And an outbreak needs a cluster, not a national average. This is why measles outbreaks occur in countries with high reported coverage.
Two further measures are worth asking about whenever you look at programme data:
Vaccine hesitancy attracts attention out of proportion to its size. In most settings, the majority of unvaccinated children are not the children of refusers. They are children whose families face distance, transport costs, inconvenient clinic hours, lost wages for a day of travel, or simply not knowing when the next session is.
That matters practically: access problems are both the bigger cause and the easier one to fix. A programme that spends its energy arguing with a small number of refusers while ignoring a clinic that opens only when parents are at work has misdiagnosed its problem.
Where genuine doubt does exist, it is usually about safety. The evidence on responding is fairly consistent:
Antibiotic resistance is the mirror image of herd immunity. Vaccination creates a shared benefit; antibiotic overuse creates a shared harm. Both spill over from the individual decision to the population.
Why is an antibiotic different from every other prescription? Because the harm of overusing it does not fall mainly on the patient who takes it. It falls on whoever is next infected by the resistant organisms that course selected — possibly in a different ward, a different year, a different city.
Indicated?Is there a bacterial infection at all? Most sore throats, coughs and colds are viral, and antibiotics change nothing except the resistance profile of the patient's flora.
Which agent?The narrowest drug that covers the likely organism, guided by local resistance patterns rather than habit.
What dose?Adequate — under-dosing selects resistance as effectively as over-prescribing.
Which route?Oral wherever it will work. Intravenous therapy adds line infections and keeps patients in hospital.
How long?The most neglected question. Courses continued out of habit cause harm without benefit.
Two practical habits carry most of the benefit. Take cultures before the first dose wherever doing so will not delay treatment of a seriously ill patient — after antibiotics, the chance of identifying the organism falls sharply, and you lose the ability to narrow therapy later. And review at 48 to 72 hours, when culture results and the clinical response are available: narrow the spectrum, switch to oral, or stop.
Note that stewardship is not the same as withholding antibiotics. Delayed or inadequate treatment of sepsis kills, and no stewardship policy justifies that. The aim is the right drug, promptly, for the right duration — not less treatment, but less unnecessary treatment.And the problem is bigger than hospitals. Over-the-counter sale of antibiotics without prescription, incomplete courses bought a few tablets at a time, and unregulated use in agriculture all drive resistance. A prescriber working carefully in a system that sells antibiotics freely from every shop is fighting one part of a much larger problem — which is worth saying in an exam answer, because it demonstrates that you understand where the leverage actually is.
Schedules, storage temperatures, herd immunity thresholds, coverage targets and antibiotic doses are deliberately not quoted here — all are national policy or organism-specific. Use your current national guideline.
Create a free account to tick topics off, take notes as you read, watch the video lessons and get a day-by-day study plan built around your exam date.
Loading…